Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis C virus infection after renal transplantation

Contributions to Nephrology

Volumn 176, Issue , 2012, Pages 108-116

  Cruzado, Josep M ^a   Bestard, Oriol ^a   Grinyó, Josep M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; CRYOGLOBULINEMIA; DIABETES MELLITUS; GRAFT SURVIVAL; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS;

CRYOGLOBULINEMIA; DIABETES MELLITUS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GRAFT SURVIVAL; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSION; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION;

EID: 84856820955     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000332389     Document Type: Article

References (42)

1. Sabharwal S, Delgado-Borrego A, Chung RT: Extrahepatic hepatitis C virus after trans-plantation: diabetes and renal dysfunction. Liver Transpl 2008;14(suppl 2):S51-S57.
2. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al: The natural history of community acquired hepatitis C in the United States. The Sentinel Counties Chronic Non-A, Non-B Hepatitis Study Team. N Engl J Med 1992;327:1899-1905.
3. Perico N, Cattaneo D, Bikbov B, Remuzzi G: Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol 2009;4:207-220.
4. Huskey J, Wiseman AC: Chronic viral hepatitis in kidney transplantation. Nat Rev Nephrol 2011;7:156-165.
5. Abbott KC, Lentine KL, Bucci JR, Agodoa LY, Koff JM, Holtzmuller KC, Schnitzler MA: Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus. J Am Soc Nephrol 2004;15:3166-3174. (Pubitemid 39578849)
6. Roth D, Gaynor JJ, Reddy KR, Ciancio G, Sageshima J, Kupin W, Guerra G, Chen L, Burke GW 3rd: Effect of kidney transplan-tation on outcomes among patients with hepatitis C. J Am Soc Nephrol 2011;22:1152-1160.
7. Bestard O, Cruzado JM, Torras J, Gil-Vernet S, Serón D, Moreso F, Rama I, Grinyó JM: Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival. Transplant Proc 2005;37:3774-3777. (Pubitemid 43015163)
8. Cruzado JM, Torras J, Gil-Vernet S, Grinyó JM: Glomerulonephritis associated with hepatitis C virus infection alter renal transplantation. Nephrol Dial Transplant 2000;15(suppl 8):65-67. (Pubitemid 32149512)
9. Forman JP Tolkoff-Rubin N, Pascual M, Lin J: Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol 2004;15:3249-3255. (Pubitemid 39578858)
10. Bloom RD, Lake JR: Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients. Am J Transplant 2006;6:2232-2237. (Pubitemid 44359408)
11. Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K, Kimura S, Moriya K, Koike K: Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004;126:840-848. (Pubitemid 38298332)
12. Fabrizi F, Martin P Dixit V, Bunnapradist S, Kanwal F, Dulai G: Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta-analysis of clini-cal studies. Am J Transplant 2005;5:2433-2440.
13. Räkel A, Karelis AD: New-onset diabetes after transplantation: risk factors and clinical impact. Diabetes Metab 2011;37:1-14.
14. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC: Association of hepa-titis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002;13:1374-1380. (Pubitemid 34441419)
15. Cruzado JM, Carrera M, Torras J, Grinyó JM: Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001;1:171-178. (Pubitemid 33674158)
16. Moreso F, Ibernon M, Gomá M, et al: Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006;6:747-752. (Pubitemid 43345012)
17. Cosio FG, Sedmak DD, Henry ML, Al Haddad C, Falkenhain ME, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM: The high prevalence of severe early post-transplant renal allograft pathology in hepa-titis C positive recipients. Transplantation 1996;62:1054-1059. (Pubitemid 26376650)
18. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryo-globulinemia. N Engl J Med 1992;327:1490-1495.
19. Agnello V, De Rosa F: Extrahepatic disease manifestations of HCV infection: some cur-rent issues. J Hepatol 2004;40:341-352. (Pubitemid 38115844)
20. D'Amico G, Fornasieri A: Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 1995;25:361-369.
21. Johnson RJ, Gretch Dr, Yamabe H, et al: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-470. (Pubitemid 23056436)
22. Baid S, Pascual M, Williams WW Jr, Tolkoff-Rubin N, Johnson SM, Collins B, Chung RT, Delmonico FL, Cosimi AB, Colvin RB: Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol 1999;10:146-153. (Pubitemid 29034953)
23. Roth D, Cirocco R, Zucker K, et al: De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients. Transplantation 1995;59:1676-1682.
24. Cantarell MC, Charco R, Capdevila L, et al: Outcome of hepatitis C virus-associated membranoproliferative glomerulonephritis after liver transplantation. Transplantation 1999;68:1131-1134. (Pubitemid 29517702)
25. Hestin D, Guillemin F, Castin N, et al: Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplan-tation. Transplantation 1998;65:741-744. (Pubitemid 28128949)
26. Cruzado JM, Gil-Vernet S, Ercilla G, et al: Hepatitis C virus-associated membrano-proliferative glomerulonephritis in renal allografts. J Am Soc Nephrol 1996;7:2469-2475. (Pubitemid 27465955)
27. Gallay BJ, Alpers CE, Davis CL, Schultz MF, Johnson RJ. Glomerulonephritis in renal allografts associated with hepatitis C infec-tion: a possible relationship with transplant glomerulopathy in two cases. Am J Kidney Dis 1995;26:662-667
28. Morales JM, Pascual-Capdevila J, Campistol JM, Fernandez-Zatarain G, Muñoz MA, Andres A, Praga M, Martinez MA, Usera G, Fuertes A, Oppenheimer F, Artal P Darnell A, Rodicio JL: Membranous glom-erulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation 1997;63:1634-1639. (Pubitemid 27265507)
29. Wörnle M, Schmid H, Banas B, et al: Novel role of Toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 2006;168:370-385. (Pubitemid 43271137)
30. Sansonno D, Lauletta G, Montrone M, Grandaliano G, Schena FP, Dammacco F: Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol 2005;140:498-506. (Pubitemid 40813960)
31. Natov SN, Pereira BJG: Management of hepatitis C infection in renal transplant recipients. Am J Transplant 2002;2:483-490. (Pubitemid 36306866)
32. Morales JM, Campistol JM: Disease of the month: transplantation in the patient with hepatitis C. J Am Soc Nephrol 2000;11:1343-1353. (Pubitemid 30416233)
33. Watt K, Veldt B, Charlton M: A practical guide to the management of HCV infec-tion following liver transplantation. Am J Transplant 2009;9:1707-1713.
34. Kamar N, Rostaing L, Alric L: Treatment of hepatitis C-virus-related glomerulonephritis. Kidney Int 2006;69:436-439. (Pubitemid 43164433)
35. Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D: Treatment of chronic hep-atitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995;59:1426-1431.
36. Pham HP Feray C, Samuel D, et al: Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients. Kidney Int 1998;54:1311-1319. (Pubitemid 28449920)
37. Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F: Monoclonal anti-body treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti CD-20. Blood 2003;101:3818-3826. (Pubitemid 36857852)
38. Zaja F, De Vita S, Mazzaro C, et al: Efficacy and safety of rituximab in type II cryoglobu-linemia. Blood 2003;101:3827-3834. (Pubitemid 36857853)
39. Basse G, Ribes D, Kamar N, et al: Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients. Transplantation 2005;80:1560-1564. (Pubitemid 43005866)
40. Bestard O, Cruzado JM, Ercilla G, et al: Rituximab induces regression of hepatitis C virus-related membranoproliferative glom-erulonephritis in a renal allograft. Nephrol Dial Transplant 2006;21:2320-2324. (Pubitemid 44295067)
41. Casanovas-Taltavull T, Baliellas C, Benasco C, Serrano TT, Casanova A, Pérez JL, Guerrero L, González MT, Andres E, Gil-Vernet S, Casais LA: Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemo-dialysis: results after transplantation. Am J Gastroenterol 2001;96:1170-1177. (Pubitemid 32319156)
42. Cruzado JM, Casanovas-Taltavull T, Baliellas C, Gil-Vernet S, Grinyó JM: Pretransplant interferon prevents hepatitis C virus associ-ated glomerulonephritis by HCV-RNA clear-ance. Am J Transplant 2003;3:357-360. (Pubitemid 36407057)